607 related articles for article (PubMed ID: 31309890)
1. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
Urano T; Suzuki Y; Iwaki T; Sano H; Honkura N; Castellino FJ
Curr Drug Targets; 2019; 20(16):1695-1701. PubMed ID: 31309890
[TBL] [Abstract][Full Text] [Related]
2. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
3. The Role of Fibrinolytic System in Health and Disease.
Kwaan HC
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563651
[TBL] [Abstract][Full Text] [Related]
4. Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.
Whyte CS; Mostefai HA; Baeten KM; Lucking AJ; Newby DE; Booth NA; Mutch NJ
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672724
[TBL] [Abstract][Full Text] [Related]
5. Thrombin stimulates increased plasminogen activator inhibitor-1 release from liver compared to lung endothelium.
Huebner BR; Moore EE; Moore HB; Gonzalez E; Kelher MR; Sauaia A; Banerjee A; Silliman CC
J Surg Res; 2018 May; 225():1-5. PubMed ID: 29605018
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen Activator Inhibitor-1 Reduces Tissue-Type Plasminogen Activator-Dependent Fibrinolysis and Intrahepatic Hemorrhage in Experimental Acetaminophen Overdose.
Pant A; Kopec AK; Baker KS; Cline-Fedewa H; Lawrence DA; Luyendyk JP
Am J Pathol; 2018 May; 188(5):1204-1212. PubMed ID: 29454747
[TBL] [Abstract][Full Text] [Related]
7. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
8. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
9. Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells.
Suzuki Y; Mogami H; Ihara H; Urano T
Blood; 2009 Jan; 113(2):470-8. PubMed ID: 18922856
[TBL] [Abstract][Full Text] [Related]
10. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
[TBL] [Abstract][Full Text] [Related]
11. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of physiological fibrinolysis.
Lijnen HR; Collen D
Baillieres Clin Haematol; 1995 Jun; 8(2):277-90. PubMed ID: 7549063
[TBL] [Abstract][Full Text] [Related]
13. Initiation and regulation of fibrinolysis in human plasma at the plasminogen activator level.
Wun TC; Capuano A
Blood; 1987 May; 69(5):1354-62. PubMed ID: 3105619
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of the influence of ovarian steroids on plasminogen activators and inhibitors in human endometrial cells and trophoblasts.
Ueyama M; Kasatori N; Urayama T; Maemura T; Yao Y; Shiraishi T; Saito S; Kubo H
Thromb Res; 2002 Nov; 108(4):235-44. PubMed ID: 12617987
[TBL] [Abstract][Full Text] [Related]
15. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
16. Regulation of plasminogen activation on cell surfaces and fibrin.
Urano T; Castellino FJ; Suzuki Y
J Thromb Haemost; 2018 May; 16(8):1487-97. PubMed ID: 29779246
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract][Full Text] [Related]
18. Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate.
Nielsen JD; Gram J; Fabrin K; Holm-Nielsen A; Jespersen J
Br J Urol; 1997 Jul; 80(1):105-10. PubMed ID: 9240188
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis inhibitors in plaque stability: a morphological association of PAI-1 and TAFI in advanced carotid plaque.
Jönsson Rylander AC; Lindgren A; Deinum J; Bergström GM; Böttcher G; Kalies I; Wåhlander K
J Thromb Haemost; 2017 Apr; 15(4):758-769. PubMed ID: 28135035
[TBL] [Abstract][Full Text] [Related]
20. Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1.
Meltzer ME; Lisman T; de Groot PG; Meijers JC; le Cessie S; Doggen CJ; Rosendaal FR
Blood; 2010 Jul; 116(1):113-21. PubMed ID: 20385790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
